任何原因所导致的肠道血供减少均可导致急、慢性肠系膜缺血性疾病。虽然外科血运重建及坏死肠段的切除仍然是该类疾病的标准治疗方式，但积极的支持及药物治疗是整体外科治疗方案中不可或缺的重要组成部分。对于肠管尚未出现坏死的病例，药物治疗是这类疾病的主要治疗方式；而对手术病人的围手术期用药是保证手术成败的关键；随访期间的药物治疗则是维持移植物（或支架）功能及控制危险因素的必要手段。

Drug therapy  of mesenteric ischemia        YUE Jia-ning, FU Wei-guo. Department of Vascular Surgery, Zhongshan Hospital Fudan University,Shanghai200032,China
Corresponding author：FU Wei-guo,E-mail: fu.weiguo@zs-hospital.sh.cn
Abstract    Any condition that results in the decreased blood flow to the bowel may cause acute or chronic mesenteric ischemia. While surgical revascularization and intestinal resection has still been the standard of treatment, supportive therapy and medical management play important roles in the comprehensive surgical strategy. In patients without clinical evidence of bowel infarction, conservative medical therapy may be the primary strategy. Even in the irreversible bowel ischemia, perioperative drug therapy is crucial to the success of the surgery. Long-term drug therapy may be necessary to keep the graft or stent functional, as well as to control the systematic risk factors.